MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Subthalamic nucleus(SIN)"

  • 2023 International Congress

    SAFE-DBS – A monocentric, randomised, blind evaluation of safinamide in the perioperative period in Parkinsonian patients with deep brain stimulation

    E. Gülke, M. Höfs, H. Pinnschmidt, A. Gulberti, C. Moll, U. Hidding, C. Buhmann, M. Heise, W. Hamel, M. Pötter-Nerger (Hamburg, Germany)

    Objective: This monocentric, randomised, blind study is designed to evaluate the effect of safinamide on motor and neuropsychiatric symptoms in the 3 month perioperative period…
  • 2023 International Congress

    Characteristics of cases in which stimulation was programmed for multiple targets in deep brain stimulation therapy for Parkinson’s disease.

    K. Kimura, H. Kishida, N. Ueda, T. Kawasaki, F. Tanaka (Yokohama, Japan)

    Objective: To clarify the the clinical background of Parkinson's disease patients with DBS who received multiple stimulus targets. Background: Deep brain stimulation (DBS) is an…
  • 2023 International Congress

    Predicting motor outcome and quality of life after subthalamic DBS for Parkinson’s Disease: the role of standard screening measures and wearable-data

    V. Geraedts, J. van Vugt, J. Marinus, R. Kuiper, H. Middelkoop, R. Zutt, N. vd Gaag, C. Hoffmann, L. Dorresteijn, J. van Hilten, MF. Contarino (Leiden, Netherlands)

    Objective: To evaluate the utility of universal components incorporated in the DBS screening, complemented by a wearable sensor, to predict motor outcomes and Quality of…
  • 2023 International Congress

    local field potential differences in stn subregion during performance of a conflict task in humans with parkinson’s disease

    J. Bowersock, J. Neimat, A. Alhourani, T. Stewart, S. Wylie, N. van Wouwe (Flagstaff, USA)

    Objective: Examine dorsal and ventral STN subregion's roles in motor conflict with intraoperative recordings during the implantation of a DBS device in Parkinson’s disease (PD)…
  • 2023 International Congress

    Moving beyond trial and error: a strategy for anatomically informed contact selection in subthalamic deep brain stimulation for Parkinson’s disease.

    GA. Brandt, V. Stopic, C. Hennen, JN. Strelow, JN. Petry-Schmelzer, JC. Baldermann, MT. Barbe, V. Visser-Vandevalle, TA. Dembek (Cologne, Germany)

    Objective: In this study we aimed to investigate and compare the utility of conventional DBS programming strategies and anatomically informed approaches predicting long term motor…
  • 2023 International Congress

    APOE-ɛ4 status and cognitive decline after subthalamic nucleus-deep brain stimulation in Parkinson’s disease: preliminary results of the GENEPARK-DBS study

    A. Sánchez-Soblechero, G. Lafuente, S. Pérez, G. Velilla, M. González-Sánchez, E. González-Turiño, J. Suárez, F. Grandas, V. álvarez, B. Dela Casa (Madrid, Spain)

    Objective: The aim of this study was to evaluate wheter the presence of APOE-ε4 in a cohort of Parkinson’s disease (PD) patients treated with subthalamic…
  • 2023 International Congress

    Theoretical Definition of DBS Electrode Misplacement

    I. Cruz, M. Wilken, S. Castillo-Torres, D. Cerquetti, M. Merello (Buenos Aires, Argentina)

    Objective: To propose a definition of Subthalamic Nucleus Deep Brain Stimulation (STN-DBS) electrode misplacement (MP) based on ideal brain connectivity strength. Background: MP is defined…
  • 2023 International Congress

    Deep brain stimulation impacts functional brain connectivity in Parkinson’s disease.

    R. Jech, F. Ruzicka, D. Kiakou, A. Lasica, P. Filip, K. Burdova, D. Urgosik, K. Mueller (Prague, Czech Republic)

    Objective: Deep-brain stimulation (DBS) became a successful method to treat Parkinson’s disease (PD), particularly with stimulating the subthalamic nucleus (STN-DBS), although the precise mechanisms mediating…
  • 2023 International Congress

    Tremor characteristics differentially respond to levodopa and subthalamic nucleus deep brain stimulation in Parkinson’s disease

    T. Wirth, F. Ferreira, N. Vijiaratnam, C. Girges, A. Pakzad, A. Roquemaurel, O. Sinani, J. Hyam, M. Hariz, L. Zrinzo, H. Akram, P. Limousin, T. Foltynie (Strasbourg, France)

    Objective: To identify factors predictive of responsiveness of tremor to levodopa and STN-DBS. Background: Tremor in Parkinson’s disease (PD) is phenotypically variable and has an…
  • 2023 International Congress

    Directional deep brain stimulation therapy in the long term

    E. Sanesteban Beceiro, A. Fernández Revuelta, E. López Valdés, R. García-Ramos, C. Fernández García, F. Alonso Frech (Madrid, Spain)

    Objective: To describe our long-term clinical experience with directional deep brain stimulation (d-DBS) in patients with advanced Parkinson’s disease (PD) who have been implanted with…
  • « Previous Page
  • 1
  • …
  • 3
  • 4
  • 5
  • 6
  • 7
  • …
  • 33
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley